nad has been researched along with Cognitive Dysfunction in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 7 (87.50) | 2.80 |
| Authors | Studies |
|---|---|
| Diab, J; Ferrario, E; Strømland, Ø; Sverkeli, LJ; Ziegler, M | 1 |
| Li, J; Lu, J; Nadeeshani, H; Ying, T; Zhang, B | 1 |
| Campbell, JM | 1 |
| Lei, F; Xiao, X; Zhang, F | 1 |
| Abdelghany, TM; Ahmedy, OA; El-Shamarka, MEA; El-Tanbouly, DM; Khattab, MA | 1 |
| Han, S; Ju, C; Wang, J; Zhuang, D | 1 |
| Guan, X; Jiang, G; Pang, T; Tang, L; Xie, L; Zhao, N; Zhu, X | 1 |
| Hu, X; Sakurai, T; Takata, T; Wang, X; Yang, Y | 1 |
3 review(s) available for nad and Cognitive Dysfunction
| Article | Year |
|---|---|
The balance between NAD
Topics: ADP-ribosyl Cyclase 1; Aging; Animals; Armadillo Domain Proteins; Cognitive Dysfunction; Cytoskeletal Proteins; Drug Discovery; Humans; Metabolic Diseases; NAD; Oxidation-Reduction; Poly(ADP-ribose) Polymerases; Signal Transduction; Sirtuins | 2021 |
Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns.
Topics: Aged; Aging; Cognitive Dysfunction; Humans; Longevity; NAD; Nicotinamide Mononucleotide | 2022 |
Supplementation with NAD
Topics: Animals; Cognitive Dysfunction; Dietary Supplements; Humans; NAD; Niacin; Niacinamide; Nicotinamide Mononucleotide | 2022 |
5 other study(ies) available for nad and Cognitive Dysfunction
| Article | Year |
|---|---|
Knockdown of CBX7 inhibits ferroptosis in rats with cerebral ischemia and improves cognitive dysfunction by activating the Nrf2/HO-1 pathway.
Topics: Animals; Brain Ischemia; Cognitive Dysfunction; Ferroptosis; Infarction, Middle Cerebral Artery; Ions; Iron; NAD; NF-E2-Related Factor 2; Phospholipid Hydroperoxide Glutathione Peroxidase; Polycomb Repressive Complex 1; Quinones; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Transferrin; Reperfusion Injury; RNA, Small Interfering; Superoxide Dismutase | 2022 |
Apigenin attenuates LPS-induced neurotoxicity and cognitive impairment in mice via promoting mitochondrial fusion/mitophagy: role of SIRT3/PINK1/Parkin pathway.
Topics: Animals; Apigenin; Cognitive Dysfunction; Lipopolysaccharides; Mice; Mitochondrial Dynamics; Mitophagy; NAD; Neurotoxicity Syndromes; Protein Kinases; Sirtuin 1; Sirtuin 3; Ubiquitin-Protein Ligases | 2022 |
Inhibition of neuronal Kv7 channels ameliorates MK-801-induced cognitive dysfunction in mice via up-regulating NAMPT expression.
Topics: AMP-Activated Protein Kinases; Animals; Cognitive Dysfunction; Dizocilpine Maleate; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAD; Nicotinamide Phosphoribosyltransferase | 2023 |
The Combination of Citicoline and Nicotinamide Mononucleotide Induces Neurite Outgrowth and Mitigates Vascular Cognitive Impairment via SIRT1/CREB Pathway.
Topics: Animals; Cognitive Dysfunction; Cytidine Diphosphate Choline; Dementia, Vascular; NAD; Neuroinflammatory Diseases; Neuronal Outgrowth; Nicotinamide Mononucleotide; Rats; Sirtuin 1 | 2023 |
Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Death; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory; Mitochondria; NAD; Neurons; Neuroprotective Agents; Nicotinamide Mononucleotide; Peptide Fragments; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; Tissue Culture Techniques | 2016 |